|
*** HRT *** The Fox Law Firm Is Reviewing Potential Hormone Replacement Therapy (HRT) Claims Death Breast Cancer Ovarian Cancer Heart Disease Stroke Blood Clots
Have you experienced severe health issues – such as breast-cancer, heart disease, and/or stroke - following the use of HRT? Have your loved ones suffered adversely – or even died – from the effects of HRT? If so, you should contact us immediately to protect your legal rights. If you or your loved ones have experienced any of these side effects you may have a claim for legal compensation. Contact The Fox Law Firm for superior legal representation. HRT is a specific form of medical treatment for women who are either surgically menopausal; perimenopausal (which is the specific phase prior to the onset of menopause); or postmenopausal. HRT may actively prevent – or at least lessen - the physical and emotional distress that can result from diminishing circulating estrogen and progesterone hormones in the patient’s body. HRT revolves around the utilization of a body of medications that are designed to help artificially boost the patient’s hormone levels. The specific groups of hormones involved are estrogens, progesterone or progestins, and sometimes testosterone. Hormone replacement therapy can result in a large variety of none-life-threatening side effects, such as: headache; upset stomach; stomach cramps or bloating; diarrhea; appetite and weight changes; changes in sex drive or performance; nervousness; brown or black patches on the skin; acne; and swelling of hands, feet, or lower legs as a result of fluid retention. Far more serious – and potentially deadly - side-effects have been reported in women taking HRT, however. Public attitudes towards the widespread use of HRT in menopausal patients were altered radically in 2002. In that year, a statement was released by the Women's Health Initiative (WHI) of the National Institutes of Health, in which it was revealed that the use of a specific treatment that played a significant part in the WHI study coincided with elevated levels of cancer, stroke, and heart disease. The treatment at issue was Prempro. Used in the treatment of a variety of menopause-connected symptoms, including hot-flashes, thinning of the bones, and vaginal burning, irritation, and dryness, Prempro is a combination of of conjugated estrogens and medroxyprogesterone. Conjugated estrogens are a mixture of estrogen hormones; Medroxyprogesterone is an important factor in the regulation of both ovulation and menstruation. The findings of the WHI were eye-opening and disturbing, and revealed that specific estrogen-progestin HRT treatment had resulted in a noticeable increase in potentially fatal side-effects, which included (A) a 29-per-cent increase in heart disease; (B) a 26-per-cent rise in breast cancer; (C) a 41-per-cent increase in strokes; and (D) a doubling of the risk of developing blood-clots. The discoveries of the WHI were supported by the conclusions of an ambitious, nationwide study undertaken in Britain known as the Million Women Study. As a result of the collective Anglo-American discoveries, the rate of women actively prescribed and using hormone treatment dropped by almost fifty-per-cent. In the wake of the above-announcements, a warning published in the pages of the Journal of the American Medical Association stated that women with normal menopause – as opposed to surgical menopause - should only take prescribed HRT treatment at the lowest dose possible, and for the shortest period of time considered permissible. In March 2006, the Journal of Cancer stated that post-menopausal women prescribed HRT had an elevated risk of developing breast-cancer. Additional Information:
|
